Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$2,336.7M | ($284.7M) | 6.1 | 16.0x | 15.7x | 4.3x | (130.3x) | 0.0% | 1.4% | |
$124.8B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$77.0B | ($15.9B) | 6.6 | 33.5x | 29.7x | (4.4x) | 65.2x | 3.0% | 5.7% | |
$34.4B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$30.7B | ($1,398.5M) | 6.9 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$24.0B | (€16.5B) | 6.8 | 7.5x | 7.3x | 71.9x | (11.5x) | 3.5% | 1.3% | |
$14.5B | $5,841.4M | 4.7 | 1.4x | 1.4x | 2.1x | 12.3x | 0.0% | 73.6% | |
$13.8B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$13.4B | ($535.0M) | 6.1 | 5.3x | 3.0x | (1.1x) | 38.5x | 3.7% | 10.7% | |
$13.3B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$1,846.9M | ($1,600.5M) | 4.3 | 1.9x | 1.6x | 1.5x | N/A | 0.9% | 32.1% |
The Longboard Pharmaceuticals, Inc. (LBPH) quick ratio is 15.7x, compared to the industry median of 4.4x and the 5-year historical average of 16.1x.
The Longboard Pharmaceuticals, Inc. (LBPH) net debt to FCF ratio is 4.3x, compared to the industry median of 1.0x and the 5-year historical average of (4.4x).
Longboard Pharmaceuticals, Inc. (LBPH) FCF to interest ratio is (130.3x), compared to the industry median of (29.0x) and the 5-year historical average of (97.9x).
The Longboard Pharmaceuticals, Inc. (LBPH) total debt to equity ratio is 1.4%, compared to the industry median of 3.8% and the 5-year historical average of 0.7%.